Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Romania

Drugmakers Pay Out On Claw-Back Tax

May 2012 | Industry Trend Analysis

BMI View: Industry anger against the Romanian claw-back tax is likely to remain but in the short-term it looks like the legal actions to fight it have failed. The unpredictability of this tax, as it is based on National Health Insurance House (CNAS) overspend against their own underfunded budgets, makes the levy particularly burdensome for drugmakers operating in the country.

To read the full article, please choose one of the following options:

Subcribers please log in

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries